A multiple-sclerosis drug that was at the center of Sanofi SA's SAN.FR +1.12% $20 billion takeover battle for Genzyme Corp. three years ago was approved for sale in Europe on Tuesday, the drug's first regulatory approval world-wide. The ...
BASF Corporation has entered into an agreement to commence a cash tender offer for all of the outstanding shares of common stock of the biotechnology company Verenium Corporation [Nasdaq: VRNM] for $4.00 per share. Based on all outstanding ...
Tags: Construction, Decoration
The European Medicines Agency (EMA) has granted an orphan drug status to US-based clinical-stage biotechnology company GlycoMimetics' GMI-1070 (rivipansel sodium), designed to treat vaso-occlusive crisis (VOC) in patients with sickle cell ...
The European Medicines Agency (EMA) has granted an orphan drug status to US-based clinical-stage biotechnology company GlycoMimetics’ GMI-1070 (rivipansel sodium), designed to treat vaso-occlusive crisis (VOC) in patients with sickle ...
Tags: Orphan Drug, Cell Drug
The US Food and Drug Administration (FDA) has approved breakthrough therapy designation for Danish biotechnology company Genmab and British pharmaceutical company GlaxoSmithKline’s (GSK) Arzerra (ofatumumab) in combination with ...
Tags: therapy designation, Medicine
Adaptive Biotechnologies, a biotechnology company, has secured a $2.5m Phase II small business innovation research (SBIR) award from the National Heart, Lung, and Blood Institute, a division of the NIH. The award is granted to ...
Tags: Adaptive Biotechnologies, Medicine
US-based biotechnology company Veritas Bio received a patent related to in vivo delivery of nucleic acids from the European Patent Office. Inventor Dr Pachuk noted the allowed claims cover transfecting nucleic acids into skin or muscle ...
Biotechnology company Bharat Biotech has introduced world's first clinically proven typhoid conjugate vaccine, Typbar-TCV, to protect infants aged six months and more and adults from typhoid fever caused by Salmonella typhi. Commercial ...
Tags: Bharat Biotech, Vaccine
Biotechnology company Amgen has reached a deal to buy all outstanding shares of California-based Onyx Pharmaceuticals for $125 per share in cash. The purchase price of the transaction that is expected to be closed by the beginning of ...
Tags: Amgen, Onyx Pharmaceuticals
GranBio, a Brazilian biotechnology company, and Rhodia, a Solvay Group company, have signed an agreement to create a partnership to produce bio n-butanol. Bio n-butanol is made from sugar cane straw and bagasse, the same raw material that ...
Tags: GranBio, Rhodia Partner
Biotechnology company Biocon has launched the first anti-CD6 monoclonal antibody, alzumab (Itolizumab), to treat patients with chronic plaque psoriasis in India. Indicated for the treatment of moderate-to-severe psoriasis, Alzumab is ...
GranBio, a Brazilian biotechnology company, and Rhodia, a Solvay Group company, have signed an agreement to create a partnership to produce bio n-butanol. Bio n-butanol is made from sugar cane straw and bagasse, the same raw material that ...
Tags: Granbio, Renewable Chemicals
Contract research organization Genewiz has partnered with biotechnology company BeiGene to accelerate cancer biomarker discovery to support drug target identification Under the deal, BeiGene will leverage OncoGxOne discovery cancer panels ...
Tags: Genewiz, Beigene, Cancer Biomarker Discovery
British drugmaker AstraZeneca and US biotechnology company FibroGen have formed a strategic partnership to develop and commercialize FG-4592 to treat anemia in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). ...
Tags: Anemia Drug, Astrazeneca
KU Leuven and FIT Biotech have reached a global license and partnership agreement for the development of novel immunotherapeutics leveraging FIT Biotech's gene transport unit (GTU) technology for transient in vivo expression of monoclonal ...